Skip to main content

Agios Pharmaceuticals, Inc 10-Q for FY2025 Q2

Agios Pharmaceuticals, Inc. (AGIO)

10-Q 2025-07-31 For: 2025-06-30
View Original
Added on April 10, 2026

About this 10-Q

Agios Pharmaceuticals, Inc filed this 10-Q on July 31, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$12.46M
up 44.6% from $8.62M a year earlier
Net loss
$112.02M
compared with a net loss of $96.12M a year earlier
Diluted EPS
-$1.93
compared with -$1.69 a year earlier